Skoči na glavni sadržaj

Stručni rad

Controlles clinical study of analgesic effect HWA 272 om comparison to paracetamol and placebo

Zlatko Hrgović
Senad Habibović


Puni tekst: hrvatski pdf 2.456 Kb

str. 77-82

preuzimanja: 145

citiraj

Puni tekst: engleski pdf 2.456 Kb

str. 77-82

preuzimanja: 233

citiraj


Sažetak

In the presented double blind study the analgetic effekt of single doses of 300 mg HWA 272 (l-(5-methyl-4-isoxazolyl-carbonyl) piperidine, 600 mg HWA 272, 1000 mg Paracetamol or Palcebo, mainly after an episiotomy, has been examined in two research centres. For the parametres "Alteration of pain intesity", "pain reduction" and "global judgement" there was a signifikant superiority of 600 mg HWA 272 vs. Placebo provable. Concerning "pain reduction" a significant difference, even compared with 300 mg HWA 272 and 1000 mg Paracetamol in favour of 600 mg HWA 272 has been found out.

Ključne riječi

HWA 272; paracetamol; placebo

Hrčak ID:

194639

URI

https://hrcak.srce.hr/194639

Datum izdavanja:

1.12.1993.

Podaci na drugim jezicima: hrvatski

Posjeta: 1.105 *